UK HealthCare

UK HealthCare hosts annual Cardio-Oncology Symposium

image of doctor interacting with digital image of a heart
ipopba, iStock/Getty Images Plus.

LEXINGTON, Ky. (Nov. 29, 2022) — On Dec. 3 and 4, UK HealthCare providers are hosting the annual Cardio-Oncology Symposium in the Jacobs Science Building. This event is relevant for physicians, pharmacists, cardiovascular technicians, nurses, nurse practitioners, physician assistants, radiation physicists and radiologic technicians. Cardiology, surgery, vascular and oncology residents and fellows are also welcome.

Cancer-induced heart problems affect nearly 10% of cancer patients. These problems, including a condition known as cardiotoxicity, can be caused by cancer treatments such as chemotherapy, immunotherapy or radiation therapy. Symptoms of these health issues can develop immediately during treatment, or they can develop even decades after cancer survivor’s complete treatment.

Over two half-days, this CE-accredited conference will provide state-of-the-art best practice information about continuum of cardiac care for oncology patients. It will help providers understand the interactions between cancer and cardiovascular symptoms.

“This symposium is an excellent opportunity for providers, researchers and students to come together and exchange ideas about this emerging and important field of medicine,” said Amit Arbune, M.D., director of the cardio-oncology program at UK HealthCare. “Kentucky has some of the highest rates of cancer and heart disease in the country, and collaboration between the cardio-oncologist and oncologist is imperative to ensure the best possible outcomes for our patients.”

Featured speakers include:

  • Anju Nohria, M.D., Dana-Farber Cancer Institute and Brigham and Women's Hospital;
  • Cassie Perkey, UK Markey Cancer Center;
  • Amit Arbune, M.D., UK Gill Heart & Vascular Institute;
  • Juan Carlos Lopez-Mattei, M.D., Lee Health Heart & Vascular Institute;
  • Mark E. Bernard, M.D., UK Markey Cancer Center;
  • Gregory P. Monohan, M.D., UK Markey Cancer Center;
  • John Villano, M.D., UK Markey Cancer Center; and
  • Tomas G Neilan, M.D., Massachusetts General Hospital.

For more information and to register, contact Karen Michul at

As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $501 million research and development enterprise and a world-class medical center, all on one campus.   

In 2022, UK was ranked by Forbes as one of the “Best Employers for New Grads” and named a “Diversity Champion” by INSIGHT into Diversity, a testament to our commitment to advance Kentucky and create a community of belonging for everyone. While our mission looks different in many ways than it did in 1865, the vision of service to our Commonwealth and the world remains the same. We are the University for Kentucky.